A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Clinical trial NCT02819635 · COMPLETED
Trial details
- NCT number
- NCT02819635
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-26
- Primary completion
- 2021-12-13
- Enrollment
- 1302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.